4.7 Review

The transition metals copper and iron in neurodegenerative diseases

Journal

CHEMICO-BIOLOGICAL INTERACTIONS
Volume 186, Issue 2, Pages 184-199

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2010.04.010

Keywords

Alzheimer's disease; Parkinson's disease; Amyotrophic lateral sclerosis; Huntington's disease; Copper; Iron

Funding

  1. CONACyT [51541, 83521, 47425, 203330, 207021]

Ask authors/readers for more resources

Neurodegenerative diseases constitute a worldwide health problem. Metals like iron and copper are essential for life, but they are also involved in several neurodegenerative mechanisms such as protein aggregation, free radical generation and oxidative stress. The role of Fe and Cu. their pathogenic mechanisms and possible therapeutic relevance are discussed regarding four of the most common neurodegenerative diseases, Alzheimer's. Parkinson's and Huntington's diseases as well as amyotrophic lateral sclerosis. Metal-mediated oxidation by Fenton chemistry is a common feature for all those disorders and takes part of a self-amplifying damaging mechanism, leading to neurodegeneration. The interaction between metals and proteins in the nervous system seems to be a crucial factor for the development or absence of neurodegeneration. The present review also deals with the therapeutic strategies tested, mainly using metal chelating drugs. Metal accumulation within the nervous system observed in those diseases could be the result of compensatory mechanisms to improve metal availability for physiological processes. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available